HORIBA Medical has established a partnership with BioMedica to enlarge the scope in hemostasis from routine panel to specialties

HORIBA Medical has established a partnership with BioMedica Diagnostics Inc. (BMD)

Less than 2 years after the successful launch of its Yumizen G line of hemostasis analysers and an innovative routine reagents portfolio, HORIBA Medical has established a partnership with BioMedica Diagnostics Inc. (BMD), a specialized hemostasis Canadian company and a world supplier of reagents relating to the diagnosis and research of hemostatic and thrombotic disorders.

With the addition of these specialties to its menu of liquid and ready to use routine hemostasis reagents, HORIBA Medical is now positioned to offer solutions for specialized laboratories.

HORIBA Medical is internationally recognized and present in more than 150 countries through affiliates and distributors.

Its expertise and innovative R&D in hematology has earned HORIBA Medical a world-wide reputation in the field of in vitro diagnostics. HORIBA Medical is the partner of choice for clinical and hematology/cytology laboratories and now obviously hemostasis/ thrombosis.

Yumizen G800 hemostasis analyzer

Today, HORIBA Medical is able to offer dedicated and specific solutions for Hemostasis diagnostic and treatment monitoring and to cover the needs of any laboratory.